Intrahepatic Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Intrahepatic Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-14Clinical Trial Update: Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma [Phase 2]
Phase 2 trial investigating toripalimab plus gemox as first-line therapy for intrahepatic cholangiocarcinoma is reported as ongoing with unk…
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Combined Therapy Using Oxaliplatin and Gemcitabine Chemotherapy, Lenvatinib and PD1 Antibody (JS001) for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma [Phase 2]
Phase 2 clinical trial investigating a combination of oxaliplatin and gemcitabine chemotherapy, lenvatinib, and a PD-1 antibody (JS001) for …
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Systemic Chemotherapy, Lenvatinib Plus Sintilimab for ICC With Distant Metastasis [Phase 2]
Phase 2 trial evaluating systemic chemotherapy with lenvatinib plus sintilimab for intrahepatic cholangiocarcinoma with distant metastasis i…
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma [Phase 2]
Phase 2 study assessing second-line apatinib in advanced intrahepatic cholangiocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Cisplatin and Gemcitabine Chemotherapy and Lenvatinib for Patients With Unresectable Intrahepatic Cholangiocarcinoma [Phase 2]
A Phase 2 trial evaluating cisplatin and gemcitabine chemotherapy combined with lenvatinib for unresectable intrahepatic cholangiocarcinoma …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node Metastasis [Phase 2]
A Phase 2 trial update on neoadjuvant therapy for resectable intrahepatic cholangiocarcinoma with high risk of lymph node metastasis.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors [Phase 2]
Phase 2 trial evaluating neoadjuvant therapy with a PD-1 antibody (toripalimab), GEMOX chemotherapy, and lenvatinib for resectable intrahepa…
-
CLINICAL_TRIALS trial_result · 2020-07-31Clinical Trial Update: Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma [Phase 2]
Phase II trial investigating dasatinib in IDH-mutant advanced intrahepatic cholangiocarcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma [Phase 2]
Phase 2 trial update on combining an anti-PD-1 antibody with chemotherapy for unresectable intrahepatic cholangiocarcinoma.
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Stereotactic Body Radiotherapy for Liver Tumors [NA]
Clinical trial update on stereotactic body radiotherapy for liver tumors has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma [Phase 2]
Phase 2 trial evaluating systemic chemotherapy with conventional transarterial chemoembolization in patients with unresectable intrahepatic …
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: HAIC Versus Systemic Chemotherapy for Unresectable ICC [Phase 3]
Phase 3 trial comparing hepatic arterial infusion chemotherapy (HAIC) to systemic chemotherapy for unresectable intrahepatic cholangiocarcin…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Nab-Paclitaxel Combined With Gemcitabine Adjuvant Chemotherapy After Radical Resection of Intrahepatic Cholangiocarcinoma [Phase 2]
Phase 2 trial evaluating nab-paclitaxel with gemcitabine as adjuvant therapy after radical resection of intrahepatic cholangiocarcinoma is o…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer [Phase 3]
A Phase 3 trial comparing radiation therapy to observation after gemcitabine and cisplatin for inoperable localized intrahepatic cholangioca…
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Treatment of Advanced Intrahepatic Cholangiocarcinoma [Phase 3]
Phase 3 clinical trial update for treatment of advanced intrahepatic cholangiocarcinoma (ICC).
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Lenvatinib Plus PD-1 Antibody for Unresectable ICC [Phase 2]
A Phase 2 trial of lenvatinib plus a PD-1 antibody for unresectable intrahepatic cholangiocarcinoma has been suspended.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC [Phase 2]
Phase 2 trial investigating low-dose whole-liver radiation therapy with gemcitabine and cisplatin in intrahepatic cholangiocarcinoma; study …
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma [Phase 1, Phase 2]
A clinical trial evaluating MUC-1 CAR T cells for intrahepatic cholangiocarcinoma across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: A Study of Second-line Treatment With Apatinib for Advanced Intrahepatic Cholangiocarcinoma [Phase 2]
This clinical trial update describes a Phase 2 study evaluating apatinib as second-line treatment for advanced intrahepatic cholangiocarcino…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma [Phase 2]
A Phase II trial of ceritinib (LDK378) for ROS1/ALK-overexpressed advanced intrahepatic or hilar cholangiocarcinoma has been terminated. The…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Bortezomib in Intrahepatic Cholangiocellular Carcinoma [Phase 3]
Phase 3 clinical trial evaluating bortezomib in intrahepatic cholangiocarcinoma; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma
Clinical trial update indicating the RALPPS procedure study in patients with hilar and intrahepatic cholangiocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma [Phase 1]
Phase 1 trial results evaluating stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma have been r…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma [Phase 2]
Phase 2 study of cabozantinib as monotherapy in advanced cholangiocarcinoma completed; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial of selumetinib in biliary tract cancers, including intrahepatic and extrahepatic cholangiocarcinoma, has completed with result…